[ad_1]
Not only useful for strengthening the immune system but also as a possible ally against cancer, we are talking about cannabis, as revealed by a clinical study on cannabinoids.
"You can take cannabis to prevent or delay a relapse of cancer and strengthen the immune system" The largest clinical study ever conducted on the subject was launched in Germany, as announced by scientists at the The University of Rostock in Germany who claimed the benefits after a review of more than 100 studies, the world's largest clinical trial to find out if cannabis can prevent tumors.Previous research has shown that cannabis compounds can help reduce the side effects of cancer therapies such as nausea and disease
The latest study, says Giovanni D & Agata, president of the "Rights Window", published in the British Journal of Pharmacology, found that phytocannabinoids – the most important compound in cannabis – may be responsible for the direct fight against cancer cells Researchers say that the human endocannabinoid system, responsible for brain, endocrine, and immune system functions, can be positively stimulated by phytocannabinoids. The compounds are the most notable type of "cannabinoids", and are naturally present in the cannabis plant, for example tetrahydrocannabinol, or THC, which confers on the plant its psychoactive properties and increases the size of the users. This particular compound is monitored as a marker of the potency of plants in areas of the world where cannabis is legal. Studies have shown that cannabinoids can prevent cancer cells from dividing and invading normal tissues and can block blood supply to tumors. Some studies also indicate that cannabinoids can enhance the body's immune response against the growth and spread of tumors.
Previous study data have suggested that cannabinoids have effects on different levels of cancer progression, including cancer cell proliferation, invasion, and chemoresistance. Researchers have observed continuities across the wide range of studies, which have shown that cannabis compounds can actively fight cancer cells. The study's author, Professor Burkhard Hinz, said: "There is still a need for more anticancer drugs." In this context, the accumulation of data from preclinical models suggests that cannabinoids cause anticancer effects on different levels of cancer progression. "Clinical studies are urgently needed to study the impact of cannabinoids on patient growth and tumor progression."
Source @ Rights Window
Source link
